Maraqa Beesan, Alkarajeh Mohammad, Almahareeq Marwa, Al-Shakhra Kamal, Al-Kalia Mai
Family Medicine Department, Family and Public Health, Ministry of Health, Hebron, Palestine.
Surgical Department, Hebron Governmental Hospital, Ministry of Health, Hebron, Palestine.
J Family Med Prim Care. 2022 Nov;11(11):7362-7366. doi: 10.4103/jfmpc.jfmpc_1396_22. Epub 2022 Dec 16.
This study aims to compare mortality and adherence to the second dose between different types of vaccines administered in Palestine.
A retrospective cohort study of individuals vaccinated against COVID-19 from February 14, 2021 through January 2022. Data were retrieved from the Palestinian Ministry of Health database and included identity number, date of birth, vaccination date, vaccine type, and mortality.
The study included 16,726 individuals who were vaccinated and later diagnosed with COVID-19. The mean age was 42.1 years, and females comprised 48.5% (8,112) of the population. Only 62.7% of individuals adhered to receiving the second dose of a vaccine, and the average duration of effectiveness of all vaccines was 126 days after completing the double dose. Seventy-five COVID-related deaths were recorded among vaccinated individuals who were significantly older ages.
Our study design demonstrated the disparity in vaccine uptake and adherence due to delay in vaccination and dependence on COVAX and other countries for the donated vaccines. It highlights the importance of a global approach and higher-income countries assisting lower-income countries in securing vaccine.
本研究旨在比较巴勒斯坦地区接种的不同类型疫苗之间的死亡率及第二剂疫苗的接种依从性。
一项针对2021年2月14日至2022年1月期间接种新冠疫苗的个体的回顾性队列研究。数据从巴勒斯坦卫生部数据库中获取，包括身份证号码、出生日期、接种日期、疫苗类型和死亡率。
该研究纳入了16726名接种疫苗且后来被诊断为感染新冠病毒的个体。平均年龄为42.1岁，女性占总人数的48.5%（8112人）。只有62.7%的个体坚持接种了第二剂疫苗，所有疫苗完成两剂接种后的平均有效时长为126天。在接种疫苗的个体中记录到75例与新冠相关的死亡病例，这些个体的年龄显著更大。
我们的研究设计表明，由于疫苗接种延迟以及依赖新冠疫苗全球获取机制（COVAX）和其他国家捐赠疫苗，在疫苗接种率和接种依从性方面存在差异。这凸显了全球合作方法以及高收入国家协助低收入国家确保疫苗供应的重要性。
